Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Late Stage Parkinson's Disease”

29 trials

Showing 20 of 29 results

Large-scale testing (Phase 3)Study completedNCT00522379
What this trial is testing

Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch

Who this might be right for
Parkinson's Disease
UCB Pharma 514
Large-scale testing (Phase 3)Study completedNCT00200512
What this trial is testing

Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months

Who this might be right for
Parkinson Disease
Mylan Bertek Pharmaceuticals 16
Early research (Phase 1)Study completedNCT03665454
What this trial is testing

PF 06412562 in Subjects With Advanced Stage Parkinson's Disease

Who this might be right for
Parkinson Disease
Milton S. Hershey Medical Center 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT06722729
What this trial is testing

A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease

Who this might be right for
Parkinson Disease
Kissei Pharmaceutical Co., Ltd. 150
Large-scale testing (Phase 3)Study completedNCT00134251
What this trial is testing

Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's Disease

Who this might be right for
Parkinson's Disease
Solvay Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00501969
What this trial is testing

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's Disease

Who this might be right for
Advanced Stage Parkinson's Disease
UCB Pharma 395
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07028632
What this trial is testing

The Safety, Feasibility and Efficacy of NouvNeu001 for Parkinson's Disease

Who this might be right for
Parkinson Disease (PD)
iRegene Therapeutics Co., Ltd. 30
Post-approval studies (Phase 4)Ended earlyNCT03968744
What this trial is testing

Effect of Safinamide on Sleep Quality in Patients With Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease (at Later Stage)
Alain Kaelin 11
Not applicableStudy completedNCT02333175
What this trial is testing

Care for Late Stage Parkinsonism

Who this might be right for
Parkinson's DiseaseLate Stage Parkinson's Disease
University College, London 184
Testing effectiveness (Phase 2)Study completedNCT00438607
What this trial is testing

Dose-Finding Safety Study of BIIB014 in Combination With Levodopa in Moderate to Late Stage Parkinson's Disease

Who this might be right for
Parkinson's Disease
Biogen 83
Large-scale testing (Phase 3)Study completedNCT00145171
What this trial is testing

A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.

Who this might be right for
Parkinson Disease
Mylan Bertek Pharmaceuticals 56
Testing effectiveness (Phase 2)Study completedNCT01631812
What this trial is testing

A Long-Term Extension Trial From Late Phase II of SPM 962 in Advanced Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Otsuka Pharmaceutical Co., Ltd. 130
Very early researchLooking for participantsNCT07100171
What this trial is testing

Evaluation of GM101 Injection in Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Genemagic Biosciences Co., Ltd 10
Large-scale testing (Phase 3)Study completedNCT00244387
What this trial is testing

Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa

Who this might be right for
Parkinson Disease, Idiopathic
UCB Pharma 506
Early research (Phase 1)Study completedNCT04630860
What this trial is testing

Evaluate the Pharmacokinetics and Safety of LY03003 in Patients With Advanced-stage PD

Who this might be right for
Parkinson Disease
Luye Pharma Group Ltd. 30
Early research (Phase 1)Study completedNCT00292227
What this trial is testing

Cardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's Disease

Who this might be right for
Parkinson's Disease
UCB Pharma 130
Not applicableUnknownNCT03552861
What this trial is testing

Standardization and Optimization of TMS Protocols for the Treatment of PD With Depression or Cognitive Impairment

Who this might be right for
TMS Protocols in the Treatment of PD
Guangdong Provincial People's Hospital 252
Large-scale testing (Phase 3)Study completedNCT01286935
What this trial is testing

18-month Study of Long-term Efficacy & Safety of Safinamide as add-on Therapy in Patients With Mid-late Stage PD

Who this might be right for
Parkinson's Disease
Newron Pharmaceuticals SPA 544
Testing effectiveness (Phase 2)Study completedNCT03621046
What this trial is testing

Use of Low-dose Zolpidem in Parkinson's Disease

Who this might be right for
Parkinson Disease
Aston University 28
Large-scale testing (Phase 3)Study completedNCT00406588
What this trial is testing

SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations

Who this might be right for
Advanced Stage Parkinson's Disease
Solvay Pharmaceuticals 295
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation